Image by Gabriela Camerotti via Flickr
Those suffering from a damaged heart can be treated with their own heart cells. According to a recent research, heart stem cells from children with congenital heart disease can rebuild the damaged heart in the laboratory. The findings apparently have great significance in the health zone.
While conducting the research, cells were achieved from patients ranging in age from a few days after birth to 13 years. These patients were previously subjected to routine congenital cardiac surgery. The number of heart stem cells appears greatest in neonates, that reduce with progression in age. Majority of
The symptoms of multiple sclerosis could be reversed thanks to stem cell transplants from the patient’s own bone marrow, according to a study that will be published in March in Lancet Neurology by researchers from Northwestern University Feinberg School of Medicine in Chicago, who say that stem cell transplants could restore the immune system of patients suffering from the disease, stopping its evolution, and even causing its regression.
Multiple sclerosis is an autoimmune disease characterized by a defective immune system, which attacks the body’s own tissues in the central nervous system, and effects 57 thousand Italians. The disease
Transplanting own stem cells into heart of severe angina patients lessens their pain and improves their ability to walk, a new study has revealed.
The largest national stem cell study for heart disease showed that transplant subjects also experienced fewer deaths than those who didn’t receive stem cells.
In the 12-month Phase II, double-blind trial, subjects’ own purified stem cells, called CD34+ cells, were injected into their hearts in an effort to spur the growth of small blood vessels that make up the microcirculation of the heart muscle (…)
He also said that this study provides the first evidence that a person’s
A medical model developed for regenerating bladders by using stem cells
Researchers in the United States have developed a medical model for regenerating bladders using stem cells harvested from a patient’s own bone marrow. The research, published in STEM CELLS, is especially relevant for paediatric patients suffering from abnormally developed bladders, but also represents another step towards new organ replacement therapies.
The research, led by Dr Arun Sharma and Earl Cheng from the Feinberg School of Medicine at Northwestern University and Children’s Memorial Research Center, focused on bone marrow mesenchymal stem cells (MSCs) taken from the patient. Previously studies into the
A particular type of stem cell transplantation using the patient’s own cells led to short-term freedom from insulin injections in 20 of 23 patients newly diagnosed with type 1 diabetes participating in an experimental protocol in Brazil.
One patient even managed to go four years without needing outside sources of insulin, although the average was 31 months, said the authors of a report in the April 15 issue of the Journal of the American Medical Association, a themed issue on diabetes.
The patients also kept their blood sugar under control, which is key to preventing complications from diabetes. And, the authors